Bioray Biotech Co., Ltd (TPEX:7561)
Taiwan · Delayed Price · Currency is TWD 15.90
-0.40 (-2.45%)
Nov 10, 2026, 11:17 AM CST
Bioray Biotech Market Cap
Bioray Biotech has a market cap or net worth of 470.41 million as of November 10, 2026. It is the 39,604th most valuable company in the world and the 2,281st biggest in Taiwan. Its market cap has decreased by 31.91% in one year.
Market Cap
470.41M
Enterprise Value
432.18M
Revenue
207.17M
Global Rank
Country Rank
#2,281 Taiwan
PE Ratio
24.52
ChartMarket Cap Chart
Since July 6, 2020, Bioray Biotech's market cap has decreased from 1.94B to 470.41M, a decrease of -75.76%. That is a compound annual growth rate of -20.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 519.93M | -15.91% |
| Dec 31, 2025 | 618.33M | -2.69% |
| Dec 31, 2024 | 635.45M | -31.65% |
| Dec 29, 2023 | 929.63M | 3.17% |
| Dec 30, 2022 | 901.05M | -30.18% |
| Dec 30, 2021 | 1.29B | 56.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anxo Pharmaceutical | 1.17B |
| GeneFerm Biotechnology | 1.10B |
| InnoPharmax | 1.08B |
| Excelsior Biopharma | 1.07B |
| Original BioMedicals | 1.02B |
| Prince Pharmaceutical | 1.00B |
| DV Biomed | 847.36M |
| Mediera | 784.02M |